Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Phosphatidyl-serine | hsa00030 | Pentose phosphate pathway | 4.23E-02 | 2 | P51854, P37837 | TKTL1, TALDO1 | More | | Phosphatidyl-serine | hsa00100 | Steroid biosynthesis | 3.94E-02 | 1 | P35610 | SOAT1 | More | | Phosphatidyl-serine | hsa00190 | Oxidative phosphorylation | 8.71E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Phosphatidyl-serine | hsa00220 | Arginine biosynthesis | 2.64E-04 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Phosphatidyl-serine | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.40E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Phosphatidyl-serine | hsa00310 | Lysine degradation | 3.23E-02 | 2 | Q9NVH6, O15047 | TMLHE, SETD1A | More | | Phosphatidyl-serine | hsa00440 | Phosphonate and phosphinate metabolism | 4.55E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Phosphatidyl-serine | hsa00471 | D-Glutamine and D-glutamate metabolism | 3.94E-02 | 1 | P49448 | GLUD2 | More | | Phosphatidyl-serine | hsa00531 | Glycosaminoglycan degradation | 3.78E-02 | 1 | P15586 | GNS | More | | Phosphatidyl-serine | hsa00561 | Glycerolipid metabolism | 4.62E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | | Phosphatidyl-serine | hsa00562 | Inositol phosphate metabolism | 4.55E-02 | 2 | P27987, P42338 | ITPKB, PIK3CB | More | | Phosphatidyl-serine | hsa00564 | Glycerophospholipid metabolism | 6.20E-04 | 5 | Q6P1A2, Q9Y259, P23743, P49619, Q3LIE5 | MBOAT5, CHKB, DGKA, DGKG, ADPRM | More | | Phosphatidyl-serine | hsa00620 | Pyruvate metabolism | 2.88E-03 | 4 | P40925, P40926, P51648, P14550 | MDH1, MDH2, ALDH3A2, AKR1A1 | More | | Phosphatidyl-serine | hsa00740 | Riboflavin metabolism | 4.55E-02 | 1 | Q969G6 | RFK | More | | Phosphatidyl-serine | hsa00785 | Lipoic acid metabolism | 2.01E-03 | 2 | O43766, Q9Y234 | LIAS, LIPT1 | More | | Phosphatidyl-serine | hsa00910 | Nitrogen metabolism | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Phosphatidyl-serine | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.33E-02 | 1 | P14868 | DARS | More | | Phosphatidyl-serine | hsa00983 | Drug metabolism - other enzymes | 2.83E-02 | 3 | P20839, P32320, P05164 | IMPDH1, CDA, MPO | More | | Phosphatidyl-serine | hsa01100 | Metabolic pathways | 4.40E-04 | 26 | P21953, Q9UJ14, P15104, P42338, P27987, Q96DU7, Q02153, P40926, O94777, P53004, Q86XP1, P14550, Q9UHK6, Q86VZ5, Q96G23, P09917, Q9UNP4, P32321, P49448, Q9BPW9, P46976, P05496, Q99437, O15239, O15047, Q9NVH6 | BCKDHB, GGTL3, GLUL, PIK3CB, ITPKB, ITPKC, GUCY1B3, MDH2, DPM2, BLVRA, DGKH, AKR1A1, AMACR, SGMS1, LASS2, ALOX5, ST3GAL5, DCTD, GLUD2, DHRS9, GYG1, ATP5G1, ATP6V0B, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 0.765 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | -0.722 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P15104 | GLUL | Glutamine synthetase | -0.819 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.745 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | 0.85 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | 0.761 | Q86XP1 | DGKH | Diacylglycerol kinase eta | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | -0.734 | Q86XP1 | DGKH | Diacylglycerol kinase eta | O94777 | DPM2 | Dolichol phosphate-mannose biosynthesis regulatory protein | -0.715 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P53004 | BLVRA | Biliverdin reductase A | 0.901 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q86XP1 | DGKH | Diacylglycerol kinase eta | 1 | Q86XP1 | DGKH | Diacylglycerol kinase eta | P14550 | AKR1A1 | Aldo-keto reductase family 1 member A1 | -0.778 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.908 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.834 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q96G23 | LASS2 | Ceramide synthase 2 | 0.756 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.705 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | 0.743 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P32321 | DCTD | Deoxycytidylate deaminase | 0.79 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | 0.74 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | -0.798 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P46976 | GYG1 | Glycogenin-1 | -0.82 | Q86XP1 | DGKH | Diacylglycerol kinase eta | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | -0.721 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | -0.703 | Q86XP1 | DGKH | Diacylglycerol kinase eta | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | -0.754 | Q86XP1 | DGKH | Diacylglycerol kinase eta | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | -0.709 | Q86XP1 | DGKH | Diacylglycerol kinase eta | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.858 |
| Phosphatidyl-serine | hsa01240 | Biosynthesis of cofactors | 1.10E-02 | 3 | Q969G6, O43766, Q9Y234 | RFK, LIAS, LIPT1 | More | | Phosphatidyl-serine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.32E-02 | 3 | P17252, P19174, Q9NRA1 | PRKCA, PLCG1, PDGFC | More | | Phosphatidyl-serine | hsa01524 | Platinum drug resistance | 3.91E-02 | 2 | Q14790, P48023 | CASP8, FASLG | More | | Phosphatidyl-serine | hsa03010 | Ribosome | 7.34E-03 | 6 | P62753, P62829, P62888, P61927, P61513, P36578 | RPS6, RPL23, RPL30, RPL37, RPL37A, RPL4 | More | | Phosphatidyl-serine | hsa03015 | mRNA surveillance pathway | 3.86E-02 | 3 | Q13362, Q14738, Q9UBU9 | PPP2R5C, PPP2R5D, NXF1 | More | | Phosphatidyl-serine | hsa03020 | RNA polymerase | 2.51E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | | Phosphatidyl-serine | hsa03040 | Spliceosome | 4.19E-02 | 5 | Q14562, O43143, Q07955, Q13243, P11142 | DHX8, DHX15, SFRS1, SFRS5, HSPA8 | More | | Phosphatidyl-serine | hsa03320 | PPAR signaling pathway | 4.02E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | | Phosphatidyl-serine | hsa04010 | MAPK signaling pathway | 1.53E-02 | 2 | Q9H2K8, Q12933 | TAOK3, TRAF2 | More | | Phosphatidyl-serine | hsa04012 | ErbB signaling pathway | 2.32E-02 | 3 | P16333, P17252, P19174 | NCK1, PRKCA, PLCG1 | More | | Phosphatidyl-serine | hsa04014 | Ras signaling pathway | 8.91E-03 | 6 | Q9NRA1, P49767, P17252, P0DP23, P62873, P19174 | PDGFC, VEGFC, PRKCA, CALM1, GNB1, PLCG1 | More | | Phosphatidyl-serine | hsa04015 | Rap1 signaling pathway | 1.38E-03 | 7 | Q9NRA1, P49767, P11215, P25116, P0DP23, P17252, P19174 | PDGFC, VEGFC, ITGAM, F2R, CALM1, PRKCA, PLCG1 | More | | Phosphatidyl-serine | hsa04020 | Calcium signaling pathway | 2.81E-03 | 6 | P17252, P19174, P25116, P0DP23, Q9NRA1, P49767 | PRKCA, PLCG1, F2R, CALM1, PDGFC, VEGFC | More | | Phosphatidyl-serine | hsa04062 | Chemokine signaling pathway | 2.94E-02 | 4 | P07948, P42338, P50151, P49407 | LYN, PIK3CB, GNG10, ARRB1 | More | | Phosphatidyl-serine | hsa04064 | NF-kappa B signaling pathway | 3.99E-02 | 6 | P10415, Q13489, P29965, Q9UDY8, Q8WV28, Q13315 | BCL2, BIRC3, CD40LG, MALT1, BLNK, ATM | More | | Phosphatidyl-serine | hsa04068 | FoxO signaling pathway | 1.25E-02 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | | Phosphatidyl-serine | hsa04070 | Phosphatidylinositol signaling system | 1.14E-03 | 5 | P19174, P0DP23, Q14643, P23743, P17252 | PLCG1, CALM1, ITPR1, DGKA, PRKCA | More | | Phosphatidyl-serine | hsa04071 | Sphingolipid signaling pathway | 3.68E-04 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415, Q12933, Q02156 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2, TRAF2, PRKCE | More | | Phosphatidyl-serine | hsa04072 | Phospholipase D signaling pathway | 7.45E-03 | 5 | P25116, P19174, P17252, P23743, Q9NRA1 | F2R, PLCG1, PRKCA, DGKA, PDGFC | More | | Phosphatidyl-serine | hsa04080 | Neuroactive ligand-receptor interaction | 2.16E-02 | 7 | P08311, Q15722, P21453, Q9H228, P21462, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, FPR1, C5AR1, ADRB2 | More | | Phosphatidyl-serine | hsa04110 | Cell cycle | 2.90E-02 | 4 | Q9UBD5, P06493, P30304, P33981 | ORC3, CDK1, CDC25A, TTK | More | | Phosphatidyl-serine | hsa04141 | Protein processing in endoplasmic reticulum | 8.33E-05 | 11 | P27824, P30101, Q15437, Q86TM6, P0DMV8, P11142, Q9H3Z4, Q8IXB1, P08238, Q9NR31, Q9UNL2 | CANX, PDIA3, SEC23B, SYVN1, HSPA1A, HSPA8, DNAJC5, DNAJC10, HSP90AB1, SAR1A, SSR3 | More | | Phosphatidyl-serine | hsa04145 | Phagosome | 9.65E-07 | 14 | O75015, P11215, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P27824, P13765 | FCGR3B, ITGAM, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, CANX, HLA-DOB | More | | Phosphatidyl-serine | hsa04151 | PI3K-Akt signaling pathway | 2.94E-03 | 11 | P25116, Q9NRA1, P49767, Q13362, P08238, P62873, P16144, O60603, P01568, P10415, P17252 | F2R, PDGFC, VEGFC, PPP2R5C, HSP90AB1, GNB1, ITGB4, TLR2, IFNA21, BCL2, PRKCA | More | | Phosphatidyl-serine | hsa04210 | Apoptosis | 1.67E-02 | 3 | Q14790, P48023, P42575 | CASP8, FASLG, CASP2 | More | | Phosphatidyl-serine | hsa04217 | Necroptosis | 2.06E-06 | 13 | P01568, Q13489, Q9NQC7, P42224, P07900, P08238, P15104, P01584, Q6FI13, P10415, Q9H444, O43633, Q08752 | IFNA21, BIRC3, CYLD, STAT1, HSP90AA1, HSP90AB1, GLUL, IL1B, H2AC18; H2AC19, BCL2, CHMP4B, CHMP2A, PPID | More | | Phosphatidyl-serine | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.38E-04 | 9 | P09493, P67936, P63092, Q13362, Q14738, P0DP23, P17252, P10415, P23634 | TPM1, TPM4, GNAS, PPP2R5C, PPP2R5D, CALM1, PRKCA, BCL2, ATP2B4 | More | | Phosphatidyl-serine | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Phosphatidyl-serine | hsa04330 | Notch signaling pathway | 3.98E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Phosphatidyl-serine | hsa04340 | Hedgehog signaling pathway | 3.91E-02 | 1 | P17612 | PRKACA | More | | Phosphatidyl-serine | hsa04360 | Axon guidance | 2.19E-02 | 3 | P42338, O14639, P24844 | PIK3CB, ABLIM1, MYL9 | More | | Phosphatidyl-serine | hsa04370 | VEGF signaling pathway | 2.91E-02 | 2 | P19174, P17252 | PLCG1, PRKCA | More | | Phosphatidyl-serine | hsa04540 | Gap junction | 1.73E-05 | 6 | P17252, Q13509, P68371, Q71U36, Q9NRA1, Q14643 | PRKCA, TUBB3, TUBB2C, TUBA1A, PDGFC, ITPR1 | More | | Phosphatidyl-serine | hsa04610 | Complement and coagulation cascades | 4.10E-02 | 3 | P25116, P01042, P11215 | F2R, KNG1, ITGAM | More | | Phosphatidyl-serine | hsa04611 | Platelet activation | 1.30E-04 | 5 | Q7LDG7, Q9Y490, Q8WYR1, P63092, P17612 | RASGRP2, TLN1, PIK3R5, GNAS, PRKACA | More | | Phosphatidyl-serine | hsa04612 | Antigen processing and presentation | 7.18E-04 | 11 | P13765, P48382, P26715, P26717, Q13241, P01732, P30101, P27824, P08238, P11142, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, PDIA3, CANX, HSP90AB1, HSPA8, TNF | More | | Phosphatidyl-serine | hsa04613 | Neutrophil extracellular trap formation | 1.80E-03 | 15 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P68431, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1 | More | | Phosphatidyl-serine | hsa04621 | NOD-like receptor signaling pathway | 2.92E-02 | 3 | P01584, P07900, P43490 | IL1B, HSP90AA1, PBEF1 | More | | Phosphatidyl-serine | hsa04622 | RIG-I-like receptor signaling pathway | 1.38E-03 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Phosphatidyl-serine | hsa04650 | Natural killer cell mediated cytotoxicity | 3.02E-04 | 13 | P19174, P04141, P01375, P17252, O60880, P20963, P29350, P01568, Q13241, P26718, O75015, P26717, P26715 | PLCG1, CSF2, TNF, PRKCA, SH2D1A, CD247, PTPN6, IFNA21, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Phosphatidyl-serine | hsa04657 | IL-17 signaling pathway | 3.33E-03 | 7 | P07900, O00463, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Phosphatidyl-serine | hsa04658 | Th1 and Th2 cell differentiation | 1.26E-02 | 6 | Q04759, P20963, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, STAT4, GATA3, TBX21, HLA-DOB | More | | Phosphatidyl-serine | hsa04660 | T cell receptor signaling pathway | 5.84E-03 | 8 | P01375, Q04759, P10747, O95267, Q08881, P20963, P01732, Q13191 | TNF, PRKCQ, CD28, RASGRP1, ITK, CD247, CD8A, CBLB | More | | Phosphatidyl-serine | hsa04662 | B cell receptor signaling pathway | 1.21E-02 | 3 | P42338, P60033, P07948 | PIK3CB, CD81, LYN | More | | Phosphatidyl-serine | hsa04664 | Fc epsilon RI signaling pathway | 2.96E-04 | 6 | P04141, P42338, P17252, P07948, P19174, P09917 | CSF2, PIK3CB, PRKCA, LYN, PLCG1, ALOX5 | More | | Phosphatidyl-serine | hsa04666 | Fc gamma R-mediated phagocytosis | 4.10E-02 | 3 | P19174, P14598, P17252 | PLCG1, NCF1, PRKCA | More | | Phosphatidyl-serine | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Phosphatidyl-serine | hsa04710 | Circadian rhythm | 4.40E-02 | 1 | O15516 | CLOCK | More | | Phosphatidyl-serine | hsa04713 | Circadian entrainment | 2.60E-02 | 4 | P0DP23, P17252, P62873, Q14643 | CALM1, PRKCA, GNB1, ITPR1 | More | | Phosphatidyl-serine | hsa04720 | Long-term potentiation | 3.89E-02 | 3 | P17252, P0DP23, Q14643 | PRKCA, CALM1, ITPR1 | More | | Phosphatidyl-serine | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Phosphatidyl-serine | hsa04724 | Glutamatergic synapse | 4.10E-02 | 3 | P17252, P62873, Q9NSB8 | PRKCA, GNB1, HOMER2 | More | | Phosphatidyl-serine | hsa04725 | Cholinergic synapse | 1.88E-02 | 4 | Q14643, P17252, P62873, P10415 | ITPR1, PRKCA, GNB1, BCL2 | More | | Phosphatidyl-serine | hsa04727 | GABAergic synapse | 3.63E-02 | 2 | P50151, P15104 | GNG10, GLUL | More | | Phosphatidyl-serine | hsa04728 | Dopaminergic synapse | 1.28E-03 | 7 | P63092, Q14643, P17252, P62873, Q13362, Q14738, P0DP23 | GNAS, ITPR1, PRKCA, GNB1, PPP2R5C, PPP2R5D, CALM1 | More | | Phosphatidyl-serine | hsa04740 | Olfactory transduction | 4.62E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Phosphatidyl-serine | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Phosphatidyl-serine | hsa04744 | Phototransduction | 5.68E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Phosphatidyl-serine | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.43E-03 | 4 | P19174, P17252, P0DP23, P01042 | PLCG1, PRKCA, CALM1, KNG1 | More | | Phosphatidyl-serine | hsa04810 | Regulation of actin cytoskeleton | 3.73E-03 | 7 | P00734, Q13009, P11215, P16144, Q9NRA1, P25116, P01042 | F2, TIAM1, ITGAM, ITGB4, PDGFC, F2R, KNG1 | More | | Phosphatidyl-serine | hsa04912 | GnRH signaling pathway | 3.89E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | | Phosphatidyl-serine | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Phosphatidyl-serine | hsa04924 | Renin secretion | 3.07E-05 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Phosphatidyl-serine | hsa04926 | Relaxin signaling pathway | 2.59E-02 | 3 | P42338, P50151, P49407 | PIK3CB, GNG10, ARRB1 | More | | Phosphatidyl-serine | hsa04929 | GnRH secretion | 1.40E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Phosphatidyl-serine | hsa04930 | Type II diabetes mellitus | 2.47E-02 | 1 | Q02156 | PRKCE | More | | Phosphatidyl-serine | hsa04932 | Non-alcoholic fatty liver disease | 2.26E-03 | 5 | Q14790, P48023, P01584, P12074, O15239 | CASP8, FASLG, IL1B, COX6A1, NDUFA1 | More | | Phosphatidyl-serine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 6.84E-04 | 6 | P42224, P10415, Q12778, P49767, P17252, P19174 | STAT1, BCL2, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Phosphatidyl-serine | hsa04940 | Type I diabetes mellitus | 1.55E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Phosphatidyl-serine | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.40E-02 | 1 | O00141 | SGK | More | | Phosphatidyl-serine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.76E-02 | 2 | P23634, P63092 | ATP2B4, GNAS | More | | Phosphatidyl-serine | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Phosphatidyl-serine | hsa04970 | Salivary secretion | 1.74E-02 | 4 | P07550, P22694, Q14643, P49913 | ADRB2, PRKACB, ITPR1, CAMP | More | | Phosphatidyl-serine | hsa04974 | Protein digestion and absorption | 2.47E-02 | 1 | Q7Z2H8 | SLC36A1 | More | | Phosphatidyl-serine | hsa05010 | Alzheimer disease | 4.08E-03 | 14 | P49768, Q92542, O15239, Q16718, O14521, P05496, Q14643, P0DP23, Q12933, Q13509, P68371, O15169, Q08752, P43686 | PSEN1, NCSTN, NDUFA1, NDUFA5, SDHD, ATP5G1, ITPR1, CALM1, TRAF2, TUBB3, TUBB2C, AXIN1, PPID, PSMC4 | More | | Phosphatidyl-serine | hsa05012 | Parkinson disease | 1.44E-03 | 8 | Q16718, O14521, Q14643, P19174, P0DP23, Q71U36, Q13509, P68371 | NDUFA5, SDHD, ITPR1, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | | Phosphatidyl-serine | hsa05020 | Prion disease | 1.23E-03 | 9 | P11142, Q16718, O14521, Q14643, Q71U36, Q13509, P68371, P14598, Q15080 | HSPA8, NDUFA5, SDHD, ITPR1, TUBA1A, TUBB3, TUBB2C, NCF1, NCF4 | More | | Phosphatidyl-serine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.31E-04 | 12 | Q14643, Q71U36, Q13509, P68371, P10415, Q16718, O14521, Q13561, P19174, P17252, Q08752, P0DP23 | ITPR1, TUBA1A, TUBB3, TUBB2C, BCL2, NDUFA5, SDHD, DCTN2, PLCG1, PRKCA, PPID, CALM1 | More | | Phosphatidyl-serine | hsa05110 | Vibrio cholerae infection | 2.81E-04 | 3 | Q99437, P63092, P17612 | ATP6V0B, GNAS, PRKACA | More | | Phosphatidyl-serine | hsa05130 | Pathogenic Escherichia coli infection | 8.91E-03 | 6 | Q71U36, P16333, Q13509, P68371, P25116, P29350 | TUBA1A, NCK1, TUBB3, TUBB2C, F2R, PTPN6 | More | | Phosphatidyl-serine | hsa05131 | Shigellosis | 3.33E-03 | 10 | Q12933, P68431, Q02156, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752 | TRAF2, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCE, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID | More | | Phosphatidyl-serine | hsa05132 | Salmonella infection | 1.11E-02 | 8 | Q9UJU2, Q13489, P10415, O60603, Q9BQS8, Q13561, Q13509, P68371 | LEF1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Phosphatidyl-serine | hsa05134 | Legionellosis | 1.49E-02 | 2 | Q9NR31, P0DMV8 | SAR1A, HSPA1A | More | | Phosphatidyl-serine | hsa05140 | Leishmaniasis | 1.27E-04 | 7 | P14598, P11215, P42224, P13765, O60603, P29350, Q15080 | NCF1, ITGAM, STAT1, HLA-DOB, TLR2, PTPN6, NCF4 | More | | Phosphatidyl-serine | hsa05142 | Chagas disease | 2.70E-02 | 2 | P48023, Q14790 | FASLG, CASP8 | More | | Phosphatidyl-serine | hsa05145 | Toxoplasmosis | 1.11E-02 | 6 | P10415, Q13489, P42224, P13765, O60603, P29965 | BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Phosphatidyl-serine | hsa05146 | Amoebiasis | 4.92E-02 | 5 | P09341, P01375, P05089, P22694, P08311 | CXCL1, TNF, ARG1, PRKACB, CTSG | More | | Phosphatidyl-serine | hsa05150 | Staphylococcus aureus infection | 2.66E-03 | 6 | P21730, P21462, O75015, P13765, P12838, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, DEFA4, CAMP | More | | Phosphatidyl-serine | hsa05152 | Tuberculosis | 7.93E-04 | 8 | Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Phosphatidyl-serine | hsa05162 | Measles | 4.65E-02 | 2 | P23458, P0DMV8 | JAK1, HSPA1A | More | | Phosphatidyl-serine | hsa05163 | Human cytomegalovirus infection | 4.19E-02 | 5 | P62873, P0DP23, P17252, P30101, P01568 | GNB1, CALM1, PRKCA, PDIA3, IFNA21 | More | | Phosphatidyl-serine | hsa05165 | Human papillomavirus infection | 3.56E-03 | 14 | P16144, P26012, Q05086, P46531, P49768, P01568, P42224, Q13488, Q99437, P63092, Q13362, Q12778, O15169, Q13315 | ITGB4, ITGB8, UBE3A, NOTCH1, PSEN1, IFNA21, STAT1, TCIRG1, ATP6V0B, GNAS, PPP2R5C, FOXO1, AXIN1, ATM | More | | Phosphatidyl-serine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.75E-03 | 8 | P01568, P42224, P62873, P19174, Q14643, P04141, P0DP23, Q9UJU2 | IFNA21, STAT1, GNB1, PLCG1, ITPR1, CSF2, CALM1, LEF1 | More | | Phosphatidyl-serine | hsa05170 | Human immunodeficiency virus 1 infection | 4.98E-04 | 11 | P62873, P0DP23, P17252, P30101, Q14643, P01568, O60603, Q13315, P19174, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, PDIA3, ITPR1, IFNA21, TLR2, ATM, PLCG1, BCL2, AP1M2 | More | | Phosphatidyl-serine | hsa05171 | Coronavirus disease - COVID-19 | 9.31E-04 | 12 | P01584, P42224, P01568, P62753, P36578, P62888, P61927, P61513, P62829, P04141, P19174, P17252 | IL1B, STAT1, IFNA21, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23, CSF2, PLCG1, PRKCA | More | | Phosphatidyl-serine | hsa05200 | Pathways in cancer | 1.47E-04 | 17 | P08238, P42224, P19174, Q9UJU2, P17252, P43246, P14923, P10415, Q13489, P49767, Q12778, P25116, P62873, P78417, P0DP23, P01568, P01042 | HSP90AB1, STAT1, PLCG1, LEF1, PRKCA, MSH2, JUP, BCL2, BIRC3, VEGFC, FOXO1, F2R, GNB1, GSTO1, CALM1, IFNA21, KNG1 | More | | Phosphatidyl-serine | hsa05202 | Transcriptional misregulation in cancer | 3.18E-03 | 11 | Q12778, Q13315, P41732, P14780, Q15744, Q16548, P35226, P05164, P12838, P08246, Q9C0K0 | FOXO1, ATM, TSPAN7, MMP9, CEBPE, BCL2A1, BMI1, MPO, DEFA4, ELA2, BCL11B | More | | Phosphatidyl-serine | hsa05214 | Glioma | 2.32E-02 | 3 | P0DP23, P17252, P19174 | CALM1, PRKCA, PLCG1 | More | | Phosphatidyl-serine | hsa05221 | Acute myeloid leukemia | 3.14E-02 | 3 | P14923, P11215, P04141 | JUP, ITGAM, CSF2 | More | | Phosphatidyl-serine | hsa05231 | Choline metabolism in cancer | 4.97E-04 | 6 | Q9NRA1, Q9Y259, P19174, P23743, P49619, P17252 | PDGFC, CHKB, PLCG1, DGKA, DGKG, PRKCA | More | | Phosphatidyl-serine | hsa05310 | Asthma | 6.83E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Phosphatidyl-serine | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Phosphatidyl-serine | hsa05321 | Inflammatory bowel disease | 2.27E-03 | 5 | P01375, P13765, Q14765, Q9UL17, P23771 | TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Phosphatidyl-serine | hsa05322 | Systemic lupus erythematosus | 7.03E-04 | 10 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, P29965, Q6FI13, P68431 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Phosphatidyl-serine | hsa05323 | Rheumatoid arthritis | 8.71E-04 | 6 | P01375, P13765, Q13488, P10747, P09341, O60603 | TNF, HLA-DOB, TCIRG1, CD28, CXCL1, TLR2 | More | | Phosphatidyl-serine | hsa05330 | Allograft rejection | 9.93E-04 | 4 | P13765, P29965, P10747, P01375 | HLA-DOB, CD40LG, CD28, TNF | More | | Phosphatidyl-serine | hsa05332 | Graft-versus-host disease | 4.66E-04 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Phosphatidyl-serine | hsa05410 | Hypertrophic cardiomyopathy | 2.68E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Phosphatidyl-serine | hsa05415 | Diabetic cardiomyopathy | 3.55E-02 | 5 | P17252, P14598, Q15080, Q16718, O14521 | PRKCA, NCF1, NCF4, NDUFA5, SDHD | More | | Phosphatidyl-serine | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | |